Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Copley Scientific rounds off a year of range renewal with two product upgrades

Copley Scientific
Posted on: 08 Dec 18

06 th November 2018, Nottingham, UK : Copley Scientific is closing a year of innovation and renewal across the inhaled product testing range with two upgrades that further enhance routine analysis : a new Mixing Inlet and a firmware update for the TPK ™ 2100 Critical Flow Controller. The Mixing Inlet allows application of a patient -representative inhalation profile during aerodynamic particle size distribution ( APSD) measuremen t and is used to achieve better in vitro in vivo correlations (IVIVCs) . The new , one -piece , all 316 stainless steel construction is design ed to be more robust and chemically inert for the drug recovery process . The TPK ™ 2100 Critical Flow Controller is a key accessory for flow rate control in dry powder inhaler testing (DPI) that now offers enhanced logging and recording capabilities as a result of the latest firmware update (Version 2.00) . Find out more about both products by contacting : sales@copleyscientific.co.uk
The APSD of inhaled products is a Critical Quality Attribute , measured using a cascade impactor, typically either the Andersen Cascade Impactor (ACI) or Next Generation Impactor (NGI). Cascade impactors are precision instruments that operate at a constant volumetric air flow rate. T he Mi xing Inlet decoupl es flow through the test product from that entering the impactor making it possible to apply a clini cally realistic inhalation profile during measurement while meeting the constraint of constant flow, at a calibrated rate , at the inlet to the impactor.
Available in both ACI and NGI versions , the new Mixing Inlet has a 316 stainless steel construction to aid drug recovery and optimise drug/solvent compatibility . A one -piece , rigid design offers enhanced induction port support and protects the sharp edge of the inner cone from damage ; the avoidance of internal ‘O’ rings also eliminat es a potential source of lea ks. By gently mix ing sample -laden air with any supplementary air required , the Mixing Inlet pro duce s a homogeneous test flow for the impactor, w hile minimising internal drug loss es.
The key function of the TPK ™ 2100 is to control the air flow entering the impactor for DPIs , ensuring stable , critical flow and a defined pressure drop across the inhaler - 4 kPa when applying compendial test methods. Th is pressure drop (P1) is now recorded and logged for every test provid ing a traceable record of compliance and correct inhaler operation . This additional PR_COP_JOB_ 1012 2 | Page functionality further boosts the utility of the TPK ™ 2100 ; existing units can be upgraded to the latest software version for a fee .
To see Copley’s full range of equipment fo r inhaled drug testing download “Quality Solutions for Inhaled Testing” from : http://www.copleyscientific.com/downloads/brochures

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 08/12/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.